NDC product
Cyclobenzaprine Hydrochloride
NDC 0615-8084 · NCS HealthCare of KY, LLC dba Vangard Labs
Key facts
| Product NDC | 0615-8084 |
|---|---|
| Proprietary name | Cyclobenzaprine Hydrochloride |
| Nonproprietary name | Cyclobenzaprine |
| Substances | CYCLOBENZAPRINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | NCS HealthCare of KY, LLC dba Vangard Labs |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA090478 |
| Pharmacologic classes | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| Marketing start | Jul 22, 2016 |
| Marketing end | May 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory